DOI: 10.3290/j.qi.a32639, ID de PubMed (PMID): 25191673Páginas 869-874, Idioma: InglésLustosa, Rômulo Maciel / Iwaki, Lilian Cristina Vessoni / Tolentino, Elen de Souza / Chicarelli da Silva, Mariliani / de Oliveira Lazarin, Rafael / Iwaki Filho, LiogiRecombinant human bone morphogenetic protein-type 2 (rhBMP-2) is used in oral and maxillofacial procedures due to its endochondral bone formation capacity, and this is also the reason for its use off-label in jaw reconstruction. This study reports a case of an extensive central giant cell lesion along the mandibular body and symphysis. Treatment consisted of enucleation and curettage followed by off-label use of rhBMP-2 associated with bovine bone xenograft. The literature concerning mandibular reconstruction using rhBMP-2 was also reviewed.
Palabras clave: bone graft, bone morphogenetic protein-type 2, mandibular reconstruction, xenograft
